Biocon Biologics to buy biosimilars business of Viatris for up to $3.3bn

Biocon Biologics Limited (BBL), a subsidiary of Indian biopharma company Biocon, has agreed to acquire the biosimilars business of Viatris, a US-based pharma company, in ... Read More